Histogenesis of congenital and acquired melanocytic nevi: A unifying concept [5]

American Journal of Dermatopathology

Volumn 28, Issue 4, 2006, Pages 377-379

  Saida, Toshiaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINEAGE; GENE MUTATION; HISTOGENESIS; HUMAN; KERATINOCYTE; LETTER; MELANOCYTE; MELANOCYTIC NEVUS; MELANOGENESIS; NEURAL CREST; PATHOGENESIS; PRIORITY JOURNAL; SCHWANN CELL; SENESCENCE; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION; VIRUS ONCOGENE;

ANIMALS; CELL LINEAGE; CELL PROLIFERATION; HUMANS; NEVUS, PIGMENTED;

EID: 33746801568     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200608000-00020     Document Type: Letter

References (20)

1. Krengel S. Nevogenesis: new thoughts regarding a classic problem. Am J Dermatopathol. 2005;27:456-465.
2. Kawamura T. Uber die Herkunft der Naevuszellen und die genetische Verwandtschaft zwischen Pigmentzellnaevus, blauen Naevus und Recklinghausenscher Phacomatose. Hautarzt. 1956;7:7-14.
3. Mishima Y. Macromolecular changes in pigmentary disorders. Arch Dermatol. 1965; 91:519-557.
4. Cramer SF. The histogenesis of acquired melanocytic nevi: based on a new concept of melanocytic differentiation. Am J Dermatopathol. 1984;6(Suppl 1): 288-298.
5. Magana-Garcia M, Ackerman AB. What are nevus cells? Am J Dermatopathol. 1990; 12:93-102.
6. Happle R. What is a nevus? A proposed definition of a common medical term. Dermatology. 1995;191:1-5.
7. Robinson WA, Lemon M, Elefanty A, et al. Human acquired naevi are clonal. Melanoma Res. 1998;8:499-503.
8. Uribe P, Wistuba II, Gonzalez S. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Am J Dermatopathol. 2003;25: 365-370.
9. Ichii-Nakato N, Takata M, Takayanagi S, et al. High frequency of BRAF mutation in acquired and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol. 2006. In press.
10. Beausejour C, Krtolica A, Galimi F, et al. Reversal of human celluar senescence: roles of the p53 and p16 pathways. EMBO J. 2003;22:4212-4222.
11. Bennett DC. Human melanocyte senescence and melanoma susceptibility genes. Oncogene. 2003;22:3063-3069.
12. E600- associated senescence-like cell cycle arrested of human naevi. Nature. 2005;436:720-724.
13. Blewitt RW. Single genetic mutations can account for melanocytic naevi. Br J Dermatol. 2005;152:896-902.
14. Bastian BC, Xiong J, Frieden IJ, et al. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol. 2002;161:1163-1169.
15. Herlyn M, Berking C, Li G, et al. Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation. Melanoma Res. 2000;10:303-312.
16. Tokuda Y, Saida I, Mukai K, et al. Growth dynamics of acquired melanocytic nevi: higher reactivity of proliferating cell nuclear antigen in junctional and compound nevi than intradermal nevi. J Am Acad Dermatol. 1994;31:220-224.
17. Ackerman AB, Magana-Garcia M. Naming acquired melanocytic nevi: Unna's, Miescher's, Spitz's, Clark's. Am J Dermatopathol. 1990;12:193-209.
18. Richard MA, Grob JJ, Gouvernet J, et al. Role of sun exposure on nevus: first study in age-sex phenotype-controlled populations. Arch Dermatol. 1993;129:1280-1285.
19. Hashimoto Y, Ito Y, Kato T, et al. Expression profiles of melanogenesis-related genes and proteins in acquired melanocytic nevus. J Cutan Pathol. 2006; 33:207-215.
20. Cribier BJ, Santinelli F, Grosshans E. Lack of clinical-pathological correlation in the diagnosis of congenital naevi. Br J Dermatol. 1999;141:1004-1009.